BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation
0051750
Ordering Recommendation
Recommended reflex test for differentiating between LS and sporadic CRC in tumors showing loss of MLH1. If no BRAF mutation is detected, MLH1 promoter methylation is evaluated.
Submit With Order
Mnemonic
BRAF RFLX
Methodology
Polymerase Chain Reaction/Pyrosequencing
Performed
DNA isolation: Sun-Sat
Assay:
Mon, Wed, Fri
Reported
10-14 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Tumor tissue.  
Specimen Preparation
Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue. Tissue block will be returned after testing.
Transport tissue block or 5 unstained 5-micron slides in a tissue transport kit (ARUP supply #47808) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. (Min: 3 slides). Protect paraffin block and/or slides from excessive heat.  
Storage/Transport Temperature
Room temperature or refrigerated. Ship in cooled container during summer months.  
Unacceptable Conditions
Less than 25 percent tumor. Specimens fixed/processed in alternative fixatives (alcohol, Prefer) or heavy metal fixatives. Decalcified specimens.  
Remarks
Include surgical pathology report.  
Stability
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable  
Reference Interval
Test Number Components Reference Interval
BRAF V600E by PCR By report
MLH1 Promoter Methylation by Real-​time PCR By report
Interpretive Data
Refer to report.

This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.

See Compliance Statement B: www.aruplab.com/CS
Note
If BRAF codon 600 Mutation Detection is negative, then MLH1 Promoter Methylation will be added. Additional charges apply.
CPT Code(s)
88381; 81210; If reflexed, add 81479
Components
Component Test Code*Component Chart Name
0051751BRAF codon 600 Mutation Detection
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
  • BRAF Gene Mutation Assay
  • EGFR targeted therapy
    BRAF Mutation Analysis
  • MLH1
  • sporadic Lynch Syndrome
  • V600E